Chinese herbal formula for retinal vein blockage with swelling
Part of Eyes & vision, Heart & circulation clinical trials.
This study tests whether combining a traditional Chinese herbal formula with standard treatment can help people with retinal vein occlusion and macular edema. It looks at how the treatment affects your body's metabolism and gut bacteria, which may help reduce swelling and improve vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have retinal vein occlusion (a blockage in the vein that drains the eye) along with swelling in the central retina (macular edema).
- You need to understand what the study involves and sign a consent form agreeing to participate.
- You cannot be taking other similar Chinese herbal medicines or participating in other clinical trials.
- You cannot have other serious eye conditions, such as new blood vessel growth or certain types of glaucoma.
- You cannot have severe systemic diseases like rheumatism or lupus, or severe heart, brain, liver, or kidney problems.
- If you are pregnant or breastfeeding, you cannot join this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a tiny needle injection into the artery to dissolve a blockage in the eye's main blood supply. It may help restore vision if the blockage happened within the past week.
This trial tests whether a Chinese herbal formula called Qiqi Shengmai can help people with moyamoya disease, a condition that narrows blood vessels in the brain. It aims to see if the herbal treatment is safe and might improve symptoms.
This trial tests a new medicine called SMO1 for people with vision loss and swelling in the eye caused by a blocked vein in the retina. It involves regular eye injections to see if the medicine can reduce swelling and improve vision.
This trial tests if adding mecobalamin (a form of vitamin B12) to standard anti-VEGF eye injections helps people with vision loss caused by a blocked vein in the retina. You must have swelling in the back of the eye and have had no prior treatments for this condition.
This study uses a special eye scan (OCT) to examine the retina in people with a retinal vein occlusion—a blockage in the eye's blood vessel that can cause swelling and vision loss. The goal is to learn more about how the condition affects the retina, which may help guide treatment.
This trial tests an eye injection called OLN324 for diabetic macular edema, a condition where fluid builds up in the retina and blurs vision. The treatment aims to improve vision and reduce swelling in the eye.
Hear when a new Retinal Vein Occlusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.